Претрага
Резултати
Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG ph [2011]
Petzer, Andreas L; Fong, Dominic; Lion, Thomas; Dyagil, Irina; Masliak, Zvenyslava; Bogdanovic, Andrija D
; Griskevicius, Laimonas; Lejniece, Sandra; Goranov, Stefan; Gercheva, Liana;
Stojanovic, Aleksandar; Peytchev, Dontcho; Tzvetkov, Nikolay; Griniute, Rasa; Oucheva, Radka; Grubinger, T; Kwakkelstein, Marthin; Rancati, Francesca; Gastl, Guenther A; Wolf, Dominik;
Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial [2009]
Jassem, Jacek; Pienkowski, Tadeusz; Pluzanska, Anna; Jelic, Svetislav S; Gorbunova, Vera; Berzins, Juris; Nagykalnai, Thomas; Biganzoli, Laura; Aloe, Alessandra; Astier, Ludovic;
Munier, Stephane;
An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system (✓) [2010]
Jurišić, Vladimir ; Čolović, Nataša ; Konjević, Gordana; Minić, Ivana ; Čolović, Milica
Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT" [2010]
Petzer, Andreas L; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 20)
Management of Diffuse Hepatocellular Carcinoma (? 10 Lesions) with Doxorubicin-Loaded DC Beads Is a Safe and Effective Treatment Option [2012]
Cannon, Robert M.; Urbano, Jose; Kralj, Ivan; Bošnjaković, Petar; Martin, II Robert C.G.
Филтери
По типу